EUVIMEDObjevte EUVIMED
Crossref

From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow

Keith L. Carson

BioProcessing Journal · 2026-07-28 · 3

DOI: 10.12665/j152.carson ↗

At a glance

Journal article in BioProcessing Journal, published online on 2026-07-28. Written by Keith L. Carson.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

As biologics continue to advance at a dizzying pace, I want to take this opportunity to outline what I see as the major successes, as well as the primary challenges facing the industry. First, the science of antibody production appears to be quite settled. Significant value can be gained by finding ways to limit production batches to volumes that can be accommodated by single-use bioreactor systems...

Cite

APA

Carson, K. L. (2026). From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal, 3. https://doi.org/10.12665/j152.carson

Vancouver

Carson KL. From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal. 2026:3. doi:10.12665/j152.carson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {3},
  doi = {10.12665/j152.carson}
}
Start for free →